ADUC
Mark Identification

ADUC

Serial Number

79429112

Filing Date

May 20, 2025

Trademark by

KOWA COMPANY LTD.

Classification Information

Pharmaceutical preparations for human use for the treatment and prevention of cardiovascular disease, cerebrovascular disease, dyslipidemia, thrombosis, hyperphosphatemia, hypertension, diabetes, cancer, oncological disease, leukemia, metastasis, immunological disorder, autoimmune disease, bacterial infection, viral infection, pain, central nervous system disease, neurological disease, mood disorders, musculoskeletal disorders, kidney disease, skin disease, osteoporosis, ophthalmic disorders, sensory organ disorders, aging-related diseases; veterinary preparations for the treatment and prevention of cardiovascular disease, cerebrovascular disease, dyslipidemia, thrombosis, hyperphosphatemia, hypertension, diabetes, cancer, oncological disease, leukemia, metastasis, immunological disorder, autoimmune disease, bacterial infection, viral infection, pain, central nervous system disease, neurological disease, mood disorders, musculoskeletal disorders, kidney disease, skin disease, osteoporosis, ophthalmic disorders, sensory organ disorders, aging-related diseases; vaccines for the treatment and prevention of cardiovascular disease, cerebrovascular disease, dyslipidemia, thrombosis, hyperphosphatemia, hypertension, diabetes, cancer, oncological disease, leukemia, metastasis, immunological disorder, autoimmune disease, bacterial infection, viral infection, pain, central nervous system disease, neurological disease, mood disorders, musculoskeletal disorders, kidney disease, skin disease, osteoporosis, ophthalmic disorders, sensory organ disorders, aging-related diseases; therapeutic medicines for the treatment and prevention of cardiovascular disease, cerebrovascular disease, dyslipidemia, thrombosis, hyperphosphatemia, hypertension, diabetes, cancer, oncological disease, leukemia, metastasis, immunological disorder, autoimmune disease, bacterial infection, viral infection, pain, central nervous system disease, neurological disease, mood disorders, musculoskeletal disorders, kidney disease, skin disease, osteoporosis, ophthalmic disorders, sensory organ disorders, aging-related diseases; therapeutic antibodies for the treatment and prevention of cardiovascular disease, cerebrovascular disease, dyslipidemia, thrombosis, hyperphosphatemia, hypertension, diabetes, cancer, oncological disease, leukemia, metastasis, immunological disorder, autoimmune disease, bacterial infection, viral infection, pain, central nervous system disease, neurological disease, mood disorders, musculoskeletal disorders, kidney disease, skin disease, osteoporosis, ophthalmic disorders, sensory organ disorders, aging-related diseases.

Pharmaceuticals